tirzepatide and stomach issues Side Effects Timeline: Week by Week Month by Month for Mounjaro® and Zepbound® stomach issues with tirzepatide Ozempic,

8, 2025 Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals

Men overwhelmingly cite health-related reasons (58%), while women are far more likely to pursue GLP-1s for appearance-based goals (70%)

The real question is whether this space will mature into a legitimate, responsible arm of obesity medicine or be dismissed as a chaotic market of pill mills

By 2025, data from the NCD Risk Factor Collaboration suggest 18% of men and 21% of women globally will have obesity

As multi-agonists secure approvals, reimbursement authorities may reward stronger risk-reduction profiles, underpinning sustained GLP-1 diabetes drugs market expansion in the latter half of the decade

The firmer, more elastic skin base will hold the results longer and reduce the likelihood of looseskin, fine lines, or pronounced wrinkles